Related Experiment Videos
Fatigue and gynecologic cancer
1Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Penn State College of Medicine, Milton S. Hershey Medical Center, 500 University Drive, PA 17033, USA. golt@psu.edu
Summary
Fatigue is a common, multifactorial symptom for women with gynecologic cancers. Evaluating and treating associated conditions like anemia and pain, using guidelines, can help manage this cancer-related fatigue.
Area of Science:
- Oncology
- Gynecology
- Palliative Care
Background:
- Fatigue is a prevalent and complex symptom experienced by women diagnosed with gynecologic cancers.
- This fatigue is often multifactorial, influenced by various physiological and psychological elements.
- Commonly associated factors include anemia, cachexia, pain, and depression, all requiring careful consideration.
Purpose of the Study:
- To highlight the multifactorial nature of fatigue in gynecologic cancer patients.
- To emphasize the importance of evaluating and treating contributing factors to cancer-related fatigue.
- To introduce the National Comprehensive Cancer Network Fatigue Practice Guidelines as a valuable resource.
Main Methods:
- Literature review and synthesis of current understanding regarding cancer-related fatigue.
- Identification of common comorbidities associated with fatigue in gynecologic oncology.
- Discussion of established clinical practice guidelines for fatigue management.
Main Results:
- Fatigue in gynecologic cancer is multifactorial, not solely attributable to cancer progression.
- Anemia, cachexia, pain, and depression are significant contributors to treatment-related fatigue.
- Effective management requires addressing these underlying conditions.
Conclusions:
- Comprehensive assessment and treatment of associated conditions are crucial for managing fatigue in women with gynecologic cancers.
- The National Comprehensive Cancer Network Fatigue Practice Guidelines offer a structured approach to assessment and treatment.
- Optimizing fatigue management can improve quality of life for patients undergoing gynecologic cancer treatment.